Patient P-02074

Synthetic patientMETA-24 · Day 171 · 35–44 · M · baseline S19Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Improving

GI state

Favorable

Inflammatory state

Favorable

Nutritional resilience

Favorable

Discontinuation risk

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S19

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Toxicity-11
Inflammatory activity-4
GI instability-2
Nutritional resilience+2
Treatment adherence+2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

62 min

improving · +3.4 vs previous 14 d

Sleep duration

Wearable

8 h

stable · +0.1 vs previous 14 d

Energy level

Daily log

6.6/10

improving · +0.5 vs previous 14 d

Steps

Wearable

6,312

improving · +444 vs previous 14 d

GI burden

Companion

18/100

improving · -7.4 vs previous 14 d

Adherence

Companion

97.2 %

stable · -1.6 vs previous 14 d

Sleep quality

Wearable

61.3/100

improving · +2.7 vs previous 14 d

Glucose, CGM daily mean

CGM

123 mg/dL

stable · +0.6 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 85 from the failing basin, 2 from restoration.

Good elements to keep

Protein (supports)
perturbation · steering +12.3
Butyrate producers intact
hidden · steering +7.5
Simple carbohydrates (supports)
perturbation · steering +5.6
Protein
supporter · GI -6.2 next day
Simple carbohydrates
supporter · GI -4.1 next day

Main detractors to watch

Poor-sleep week
perturbation · steering -3

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-6.2supporter · 95%
Simple carbohydrates
-4.1supporter · 60%
Dietary fat load
-2.3no signal · 40%
Histamine load
-1.9no signal · 32%
Ultra-processed food
+1.8no signal · 29%
Alcohol
-1.7no signal · 34%
Insoluble fibre
+1no signal · 18%
Caffeine
+0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer

DNA

Fictional pharmacogenomic panel

CYP2D6 Intermediate metabolizer
Expected exposure
GLP1R rs6923761 A
Altered receptor sensitivity

Microbiome

Shannon diversity 4.2 · butyrate capacity 61/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 48 ms
Sleep: 8.0 h
Steps: 6,201
Resting HR: 74 bpm

Daily log: GI score 18, nutritional resilience 66, adherence 97.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02555	48%	S01	AD-05	no change	79
P-02277	38%	S05	AD-05	improved	92
P-02013	38%	S14	BR-03	no change	94
P-02282	37%	S01	BR-03	no change	88
P-02193	35%	S11	CR-01	improved	87
P-02354	30%	S01	CR-01	improved	78
P-02565	47%	S09	DT-01	no change	79
P-02081	43%	S20	DT-01	no change	88
P-02249	34%	S09	DT-01	improved	100
P-02337	32%	S18	DT-01	no change	100
P-02462	31%	S12	DT-01	improved	65
P-02491	30%	S09	DT-01	no change	65